Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Enzymes02:34

Enzymes

95.2K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
95.2K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.4K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.4K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

1.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
1.0K
Enzyme Kinetics01:19

Enzyme Kinetics

104.4K
Enzymes speed up reactions by lowering the activation energy of the reactants. The speed at which the enzyme turns reactants into products is called the rate of reaction. Several factors impact the rate of reaction, including the number of available reactants. Enzyme kinetics is the study of how an enzyme changes the rate of a reaction.
Scientists typically study enzyme kinetics with a fixed amount of enzyme in the controlled environment of a test tube. When more reactant, or substrate, is...
104.4K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

2.9K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K
Antimicrobial Proteins01:23

Antimicrobial Proteins

14.5K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
14.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cocktail, a Computer Program for Modelling Bacteriophage Infection Kinetics.

Viruses·2022
Same author

Tail proteins of phage SU10 reorganize into the nozzle for genome delivery.

Nature communications·2022
Same author

Population Dynamics of a Two Phages-One Host Infection System Using <i>Escherichia coli</i> Strain ECOR57 and Phages vB_EcoP_SU10 and vB_EcoD_SU57.

Pharmaceuticals (Basel, Switzerland)·2022
Same author

Complete Genome Sequence of vB_EcoP_SU7, a <i>Podoviridae</i> Coliphage with the Rare C3 Morphotype.

Microorganisms·2021
Same author

Infection Kinetics and Phylogenetic Analysis of vB_EcoD_SU57, a Virulent T1-Like <i>Drexlerviridae</i> Coliphage.

Frontiers in microbiology·2020
Same author

Global phylogeography and ancient evolution of the widespread human gut virus crAssphage.

Nature microbiology·2019

Related Experiment Video

Updated: Feb 11, 2026

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
09:59

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

1.8K

Enhancing Whole Phage Therapy and Their Derived Antimicrobial Enzymes through Complex Formulation.

Callum J Cooper1, Shazeeda Koonjan2, Anders S Nilsson3

  • 1Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, SE-10691 Stockholm, Sweden. callum.cooper@su.se.

Pharmaceuticals (Basel, Switzerland)
|April 20, 2018
PubMed
Summary

Bacteriophage therapy faces challenges due to whole phage limitations. Antimicrobial enzymes derived from phages offer an alternative, with complex formulations potentially improving efficacy for multidrug-resistant infections.

Keywords:
bacteriophagecombination therapyformulationpharmacologyproduct developmentsynergy

More Related Videos

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.5K
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.0K

Related Experiment Videos

Last Updated: Feb 11, 2026

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
09:59

Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance

Published on: July 21, 2023

1.8K
Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis
06:39

Author Spotlight: Exploring Photodynamic Therapy with Curcumin in a Murine Model for Oral Candidiasis

Published on: October 27, 2023

1.5K
Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
11:20

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos

Published on: May 12, 2020

7.0K

Area of Science:

  • Microbiology and Infectious Diseases
  • Biotechnology and Therapeutics

Background:

  • Phage therapy research is reviving due to the urgent need for new treatments against multidrug-resistant infections.
  • Despite historical use and some commercial success, whole phage products face limitations in reaching targets and host specificity.

Purpose of the Study:

  • To discuss the biological limitations of whole phage therapeutics and their derived antimicrobial enzymes.
  • To explore how advanced formulations can overcome these limitations for medical and non-medical applications.

Main Methods:

  • Review and discussion of existing literature on bacteriophage biology and therapy.
  • Comparative analysis of whole phage limitations versus antimicrobial phage-derived enzymes.
  • Exploration of complex formulation strategies for phage-based agents.

Main Results:

  • Whole phages have inherent limitations in achieving effective concentrations and possess narrow host ranges.
  • Antimicrobial enzymes derived from phages share characteristics with conventional antibiotics.
  • Complex formulations may offer solutions to enhance the delivery and efficacy of phage-based antimicrobials.

Conclusions:

  • Biological limitations hinder the widespread clinical success of whole phage therapeutics.
  • Phage-derived antimicrobial enzymes present a promising alternative with potential for broader applications.
  • Further development of advanced formulations is crucial for realizing the full therapeutic potential of phage-based agents.